Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
|  
|
in chronic myelogenous leukemia cells, silenced by promoter methylation | tumoral
| fusion
| translocation
|  
|  
|
translocation t(22;9)(q11;q34)and fusion with NUP214 in T-cell acute lymphoblastic leukemia | tumoral
| fusion
|  
|  
|  
|
EML1-ABL1 fusion due to a cryptic t(9;14)(q34;q32), in T-cell acute lymphoblastic leukemia (ALL) | tumoral
| fusion
|  
|  
|  
|
fusion gene involving ABL1 and NUP214, in T-cell acute lymphoblastic leukemia (T-ALL) | tumoral
| fusion
|  
|  
|  
|
BCR-ABL1 and ETV6-ABL1 in T-cell acute lymphoblastic leukemia | tumoral
| fusion
|  
|  
|  
|
with SFPQ in t(1;9)(p34;q34) and B cell progenitor acute lymphoid leukemia | tumoral
| fusion
|  
|  
|  
|
fusion gene SNX2-ABL1 in a pediatric case of acute lymphoblastic leukemia (ALL), arising from a t(5;9)(q22;q34) translocation | |
| mice homozygous for the c-abl mutation became runted and died 1 to 2 weeks after birth ( | |
mice homozygous for the c-abl mutation are severely affected, displaying increased perinatal mortality, runtedness, and abnormal spleen, head, eye development, and major reductions in B cell progenitors ( |
|
Abl-/- mice are osteoporotic with long bones containing thinner cortical bone and reduced trabecular bone volume ( |
|
c-Abl deficiency result in a broad spectrum of defects in cell response to genotoxic stress, including activation of Chk1 and Chk2, activation of p53, nuclear foci formation, apoptosis, and DNA repair ( |